The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
In the latest session, LifeStance Health Group Inc (NASDAQ: LFST) closed at $3.9 up 0.26% from its previous closing price of $3.89. In other words, the price has increased by $0.26 from its previous closing price. On the day, 2.02 million shares were traded. LFST stock price reached its highest trading level at $3.945 during the session, while it also had its lowest trading level at $3.85.
Ratios:
For a deeper understanding of LifeStance Health Group Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.29 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 14.81. For the most recent quarter (mrq), Quick Ratio is recorded 1.47 and its Current Ratio is at 1.47. In the meantime, Its Debt-to-Equity ratio is 0.33 whereas as Long-Term Debt/Eq ratio is at 0.29.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on July 25, 2025, initiated with a Buy rating and assigned the stock a target price of $8.
On May 27, 2025, UBS Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $8.50.
On April 08, 2025, KeyBanc Capital Markets started tracking the stock assigning a Overweight rating and target price of $9.KeyBanc Capital Markets initiated its Overweight rating on April 08, 2025, with a $9 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 16 ’25 when Ramtekkar Ujjwal sold 9,519 shares for $5.17 per share. The transaction valued at 49,213 led to the insider holds 103,916 shares of the business.
Ramtekkar Ujjwal bought 9,519 shares of LFST for $49,213 on Jun 16 ’25. On Jun 05 ’25, another insider, Ramtekkar Ujjwal, who serves as the Chief Medical Officer of the company, sold 16,000 shares for $5.94 each. As a result, the insider received 95,040 and left with 113,435 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LFST now has a Market Capitalization of 1516616448 and an Enterprise Value of 1863510016. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.18 while its Price-to-Book (P/B) ratio in mrq is 1.04. Its current Enterprise Value per Revenue stands at 1.452 whereas that against EBITDA is 36.611.
Stock Price History:
The Beta on a monthly basis for LFST is 1.13, which has changed by -0.34232718 over the last 52 weeks, in comparison to a change of 0.19283521 over the same period for the S&P500. Over the past 52 weeks, LFST has reached a high of $8.61, while it has fallen to a 52-week low of $3.74. The 50-Day Moving Average of the stock is -20.28%, while the 200-Day Moving Average is calculated to be -40.75%.
Shares Statistics:
For the past three months, LFST has traded an average of 2.20M shares per day and 2012240 over the past ten days. A total of 388.83M shares are outstanding, with a floating share count of 144.75M. Insiders hold about 62.78% of the company’s shares, while institutions hold 36.06% stake in the company. Shares short for LFST as of 1752537600 were 7998077 with a Short Ratio of 3.63, compared to 1749772800 on 9255171. Therefore, it implies a Short% of Shares Outstanding of 7998077 and a Short% of Float of 9.28.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
